, Tracking Stock Market Picks
Enter Symbol:
Puma Biotechnology (PBYI) [hlAlert]

down 54.78 %

Puma Biotechnology (PBYI) rated Outperform with price target $282 by RBC Capital Mkts

Posted on: Friday,  Jan 23, 2015  8:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Puma Biotechnology (NYSE: PBYI) on 01/23/2015, when the stock price was $196.00. Since
then, Puma Biotechnology has lost 54.78% as of 12/24/2015's recent price of $88.63.
If you would have followed this RBC Capital Mkts's recommendation on PBYI, you would have lost 54.78% of your investment in 335 days.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/23/2015 8:25 AM Buy
196.00 282.00
as of 8/27/2015
1 Week down  -1.25 %
1 Month down  -29.98 %
3 Months down  -48.06 %
1 YTD down  -54.78 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy